The toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3576-3587

  Romero, Christopher D ^a   Varma, Tushar K ^a   Hobbs, Jason B ^a   Reyes, Aimee ^a   Driver, Brandon ^a   Sherwood, Edward R ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORYL LIPID A; TOLL LIKE RECEPTOR 4;

ABDOMINAL INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIUM CONTAMINATION; BONE MARROW CELL; BURN; BURN INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HOST RESISTANCE; HYPOTHERMIA; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SURVIVAL RATE;

ANIMALS; BURNS; CYTOKINES; FEMALE; IMMUNITY, INNATE; LIPID A; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; WOUND INFECTION;

EID: 80052305941     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00022-11     Document Type: Article

References (41)

1. Arnhold, J., and J. Flemmig. Human myeloperoxidase in innate and acquired immunity. Arch. Biochem. Biophys. 500:92-106.
2. Astiz, M., A. Galera, D. Saha, C. Carpati, and E. Rackow. 1994. Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock 2:271-274.
3. Astiz, M. E., D. C. Saha, K. Brooks, C. M. Carpati, and E. C. Rackow. 1993. Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ, Shock 39:194-198.
4. Aybay, C., and T. Imir. 1998. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A, and monophosphoryl lipid A on nitric oxide, TNF-α, and IL-6 induction from RAW 264.7 macrophages. FEMS Immunol. Med. Microbiol. 22:263-273.
5. Blanque, R., C. Meakin, S. Millet, and C. R. Gardner. 1996. Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL-1β, IL-6, and TNF α. Gen. Pharmacol. 27:973-977.
6. Broad, A., D. Jones, and J. Kirby. 2006. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13:2487-2502.
7. Cavaillon, J., C. Adrie, C. Fitting, and M. Adib-Conquy. 2003. Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Res. 9:101-107.
8. Cross, A. S. 2002. Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8:83-98.
9. De Becker, G., et al. 2000. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int. Immunol. 12:807-815.
10. Elner, S. G., et al. 2005. TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression. Trans. Am. Ophthalmol. Soc. 103:126-135.
11. Flierl, M. A., et al. 2008. Functions of the complement components C3 and C5 during sepsis. FASEB J. 22:3483-3490.
12. Gutierrez-Fernandez, J., M. C. Maroto, G. Piedrola, and E. Zamora. 1987. Complement and sepsis. Allergol. Immunopathol. (Madr.) 15:145-149.
13. Henricson, B., W. Benjamin, and S. Vogel. 1990. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58:2429-2437.
14. Huang, Z., et al. 2006. Effect of transforming growth factor-beta neutralization on survival and bacterial clearance in a murine model of Pseudomonas aeruginosa burn wound infection. J. Burn Care Res. 27:682-687.
15. Jiang, H. W., W. Zhang, B. P. Ren, J. F. Zeng, and J. Q. Ling. 2006. Expression of Toll-like receptor 4 in normal human odontoblasts and dental pulp tissue. J. Endod. 32:747-751.
16. Johnson, A. G., M. Tomai, L. Solem, L. Beck, and E. Ribi. 1987. Characterization of a nontoxic monophosphoryl lipid A. Infect. Dis. 9:512.
17. Kadl, A., and N. Leitinger. 2005. The role of endothelial cells in the resolution of acute inflammation. Antioxid. Redox Signal. 7:1744-1754.
18. Lebre, M. C., et al. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127:331-341.
19. Lush, C. W., G. Cepinskas, and P. R. Kvietys. 2000. LPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-mobilization. Am. J. Physiol. Heart Circ. Physiol. 278:H853-H861.
20. Mariencheck, W. I., J. Savov, Q. Dong, M. J. Tino, and J. R. Wright. 1999. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of Pseudomonas aeruginosa. Am. J. Physiol. 277:L777-L786.
21. Morgan, B. P. 2000. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates. Methods Mol. Biol. 150:61-71.
22. Muir, A., et al. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30:777-783.
23. Murphey, E., G. Fang, and E. Sherwood. 2008. Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus. Shock 29:512-518.
24. Murphey, E. D., and E. R. Sherwood. 2006. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 26:417-424.
25. Ogawa, H., et al. 2003. Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J. Immunol. 170:5956-5964.
26. Qureshi, N., K. Takayama, and E. Ribi. 1982. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257:11808-11815.
27. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
28. Redl, H., and G. Schlag. 1999. Cytokines in severe sepsis and septic shock. Birkhauser Verlag, Basel, Switzerland.
29. Salkowski, C., G. Detore, and S. Vogel. 1997. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65:3239-3247.
30. Takayama, K., N. Qureshi, E. Ribi, and J. L. Cantrell. 1984. Separation and characterization of toxic and nontoxic forms of lipid A. Rev. Infect. Dis. 6:439-443.
31. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16:3-9.
32. Tang, S. C., et al. 2008. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 213:114-121.
33. Thoelen, S., et al. 1998. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. Vaccine 16:708-714.
34. Uhrig, A., et al. 2005. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J. Leukoc. Biol. 77:626-633.
35. Ungaro, R., M. T. Abreu, and M. Fukata. 2009. Practical techniques for detection of Toll-like receptor-4 in the human intestine. Methods Mol. Biol. 517:345-361.
36. Varma, T., et al. 2005. Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect. Immun. 73:7340-7347.
37. Wang, W., et al. 28 September 2010. TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation [Epub ahead of print.]
38. West, M. A., and A. Koons. 2008. Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J. Trauma 65:893-900.
39. Wy, C., M. Goto, R. Young, T. Myers, and J. Muraskas. 2000. Prophylactic treatment of endotoxic shock with monophosphoryl lipid A in newborn rats. Biol. Neonate 77:191-195.
40. Wynn, J. L., et al. 2008. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112:1750-1758.
41. Ziegler-Heitbrock, L. 2001. The p50-homodimer mechanism in tolerance to LPS. J. Endotoxin Res. 7:219-222.